Advanced Solutions Life Sciences Wins 2025 Product of the Year for Its 3D Bioprinting BioAssembly™ Platform
- Advanced Solutions
- 4 days ago
- 2 min read
ASLS continues to lead the 3D bioprinting industry with advancements in automated tissue manufacturing and clinical-grade biofabrication.
A Landmark Win for ASLS in 3D Bioprinting Innovation
Advanced Solutions Life Sciences (ASLS) is proud to announce that our BioAssembly™ Platform with BAB Intelligence™ has been awarded 2025 Product of the Year by the New Hampshire Tech Alliance. This recognition underscores how our platform is shaping the future of 3D bioprinting and automated tissue manufacturing.
Partner and Chief Scientist Dr. Jay Hoying presented this incredible platform on stage, and we couldn’t be more grateful for his leadership, vision, and commitment to advancing regenerative medicine. The award ceremony, held in Manchester, NH, highlighted a growing trust in the ASLS team - and our mission to bring scalable, automated biofabrication from concept to clinic.
Why the BioAssembly™ Platform Matters in the Bioprinting Market
1. Disruptive 3D Bioprinting with AI & Robotics
Our platform uniquely combines high-precision BioAssemblyBot® robotics with a LLM-powered interface in BAB Intelligence™, so users can simply describe their tissue manufacturing protocol - and the system builds it. This saves time in set-up and makes automated tissue manufacturing more accessible.
2. Bridging Lab Science and Clinical Realities
Unlike many bioprinters meant only for research, the BioAssembly™ Platform is designed for GMP-level production and point-of-care manufacturing. This is a critical step toward decentralized tissue fabrication for regenerative medicine - enabling hospitals and clinics to produce patient-specific tissue on-site.
3. Scaling Biofabrication for Regenerative Therapies
As the 3D bioprinting market expands, especially in regenerative medicine, having a scalable, reliable, and automated platform is increasingly critical. According to industry forecasts, the global 3D bioprinting market is set to grow significantly in the coming years.
What This Award Means for ASLS & Our Customers
Winning this award is a validation of our vision and our team’s relentless innovation.
It reflects:
Our commitment to democratizing automated tissue manufacturing.
The strength of our technology to drive biofabrication at scale.
Our leadership in enabling regenerative therapies using 3D bioprinting.
For our customers - including academic labs, biopharma, and clinical institutions; this win represents a step closer to faster, more reproducible, and more intelligent tissue engineering workflows.
Learn More & Connect with Us
To read all about the NH Tech Alliance, check out: https://nhtechalliance.org/2025-product-of-the-year-announced/
To learn more about BioAssembly™ Platform and BAB Intelligence™, check out: https://www.advancedsolutions.com/babintelligence
Comments